TrialJournal of translational medicine2011

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.

Omid Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.